Literature DB >> 18392720

Mixed hepato/cholangiocarcinoma with paraneoplastic hypercalcemia.

Ahmed Maarouf1, Mustapha Adham, Jean-Yves Scoazec, Christian Partensky.   

Abstract

Malignant hypercalcemia without bone metastasis may result from the abnormal secretion of parathyroid hormone (PTH) or PTH-related protein (PTH-rP). We present a case of possible PTH-rP-secreting mixed hepato/cholangiocarcinoma. In July 2000, a 52-year-old woman presented with right hypochondrial pain and weight loss. Imaging procedures revealed a 10-cm lesion involving the right hepatic lobe and the hilum. Retrohepatic inferior vena caval invasion was detected by abdominal angiography. Serum calcium was elevated, while intact PTH was undetectable. The rising level of hypercalcemia rapidly became life-threatening. Medical treatment with diphosphonate and octreotide was ineffective. Chemoembolization of the right branch of the hepatic artery, preceded by right portal vein embolization, helped regain normocalcemia and improve the patient's general condition. Extended right hepatectomy with prosthetic replacement of the vena cava and resection of the left portal vein was performed. Histopathology revealed mixed hepato/cholangiocarcinoma. Hypocalcemia appeared postoperatively but was successfully corrected. Recurrence of diffuse hepatic nodules resulted in recurrent hypercalcemia and death 3 and a half years after the surgery. This is the third case to be reported in the English-language literature. Paraneoplastic PTH-rP-induced hypercalcemia, which may be a fatal complication, can respond to arterial chemoembolization. Extensive hepatic resection may offer a good chance for survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392720     DOI: 10.1007/s00534-007-1235-4

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  3 in total

1.  Combined hepatocellular-cholangiocarcinoma producing parathyroid hormone-related protein: report of a case.

Authors:  Michinori Matsumoto; Shigeki Wakiyama; Hiroaki Shiba; Takeshi Gocho; Takeyuki Misawa; Yuichi Ishida; Mariko Itsubo; Masafumi Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2013-09-08       Impact factor: 2.549

2.  Hypercalcemia in a patient with cholangiocarcinoma: a case report.

Authors:  Ioannis D Xynos; Stavros Sougioultzis; Athanasios Zilos; Konstantinos Evangelou; Gregorios S Hatzis
Journal:  Int Arch Med       Date:  2009-10-30

3.  Two cases of humoral hypercalcemia of malignancy in metastatic cholangiocarcinoma.

Authors:  Seungtaek Lim; Jungwoo Han; Kyeong Hye Park; Won Jai Jung; Yong Kang Lee; Ara Choi; Young Jae Kim; Jong-Chan Lee; Hye Jin Choi
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.